SK134395A3 - Transdermal therapeutical agent and preparation method thereof - Google Patents
Transdermal therapeutical agent and preparation method thereof Download PDFInfo
- Publication number
- SK134395A3 SK134395A3 SK1343-95A SK134395A SK134395A3 SK 134395 A3 SK134395 A3 SK 134395A3 SK 134395 A SK134395 A SK 134395A SK 134395 A3 SK134395 A3 SK 134395A3
- Authority
- SK
- Slovakia
- Prior art keywords
- pilocarpine
- transdermal therapeutic
- transdermal
- therapeutic agent
- weight
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4313928A DE4313928C2 (de) | 1993-04-28 | 1993-04-28 | Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung |
PCT/EP1994/001281 WO1994025025A2 (de) | 1993-04-28 | 1994-04-25 | Systeme zur kontrollierten abgabe von pilocarpin |
Publications (1)
Publication Number | Publication Date |
---|---|
SK134395A3 true SK134395A3 (en) | 1997-02-05 |
Family
ID=6486612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1343-95A SK134395A3 (en) | 1993-04-28 | 1994-04-25 | Transdermal therapeutical agent and preparation method thereof |
Country Status (19)
Country | Link |
---|---|
US (1) | US5869086A (de) |
EP (1) | EP0695182A1 (de) |
JP (1) | JPH08509716A (de) |
KR (1) | KR960702308A (de) |
AU (1) | AU694115B2 (de) |
CA (1) | CA2161520A1 (de) |
CZ (1) | CZ277995A3 (de) |
DE (1) | DE4313928C2 (de) |
FI (1) | FI955161A (de) |
HR (1) | HRP940270A2 (de) |
HU (1) | HU220045B (de) |
IL (1) | IL109340A (de) |
NO (1) | NO309174B1 (de) |
NZ (1) | NZ265950A (de) |
PL (1) | PL175077B1 (de) |
SK (1) | SK134395A3 (de) |
WO (1) | WO1994025025A2 (de) |
YU (1) | YU22894A (de) |
ZA (1) | ZA942874B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU719171B2 (en) * | 1995-01-14 | 2000-05-04 | Abbott Laboratories | A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts |
DE19501022C1 (de) * | 1995-01-14 | 1996-06-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
US7052714B1 (en) * | 1999-10-13 | 2006-05-30 | Senju Pharmaceutical Co., Ltd | Ophthalmic adhesive preparations for percutaneous adsorption |
DE10246503A1 (de) * | 2002-03-26 | 2003-10-16 | Tesa Ag | Verwendung von Haftklebemassen für medizinische Verklebungen |
JP4629578B2 (ja) * | 2003-01-22 | 2011-02-09 | ニチバン株式会社 | 眼疾患治療用経皮吸収型製剤 |
US20070053964A1 (en) * | 2004-05-21 | 2007-03-08 | Akiharu Isowaki | Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
US20100160293A1 (en) * | 2005-02-17 | 2010-06-24 | Kakuji Tojo | Solid Ophthalmic Drug for External Use |
US20090082381A1 (en) * | 2005-07-26 | 2009-03-26 | Akiharu Isowaki | Percutaneously Absorbable Ophthalmic Preparation |
US20100323978A1 (en) * | 2009-06-22 | 2010-12-23 | Calvin Hanna | Non-aqueous oil delivery system for ophthalmic drugs |
WO2012048455A1 (zh) * | 2010-10-12 | 2012-04-19 | 武汉大学 | 一种抗病毒透皮吸收贴片及其制备方法 |
KR101688061B1 (ko) | 2014-10-06 | 2017-01-02 | 주식회사한국파마 | 필로카르핀 경피 흡수 제제 |
JP6526475B2 (ja) * | 2015-04-30 | 2019-06-05 | サンスター株式会社 | 経皮唾液腺投与用の唾液分泌促進剤 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3220960A (en) * | 1960-12-21 | 1965-11-30 | Wichterle Otto | Cross-linked hydrophilic polymers and articles made therefrom |
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3760805A (en) * | 1971-01-13 | 1973-09-25 | Alza Corp | Osmotic dispenser with collapsible supply container |
US4144317A (en) * | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
US3987790A (en) * | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
US4137300A (en) * | 1976-08-20 | 1979-01-30 | Ciba-Geigy Corporation | Sustained action dosage forms |
IL72684A (en) * | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
US4713244A (en) * | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
US4931279A (en) * | 1985-08-16 | 1990-06-05 | Bausch & Lomb Incorporated | Sustained release formulation containing an ion-exchange resin |
US4668506A (en) * | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
CA1295941C (en) * | 1985-08-16 | 1992-02-18 | Rajan Bawa | Sustained-release formulation comprising a hydrophobic polymer system |
US5273757A (en) * | 1987-09-01 | 1993-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Apparatus for the delivery of substances, processes for the production thereof and use thereof |
DE3743946A1 (de) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung |
US5300291A (en) * | 1988-03-04 | 1994-04-05 | Noven Pharmaceuticals, Inc. | Method and device for the release of drugs to the skin |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5008110A (en) * | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
US5021053A (en) * | 1989-07-14 | 1991-06-04 | Alza Corporation | Oral osmotic device with hydrogel driving member |
DE4002281A1 (de) * | 1990-01-26 | 1991-08-01 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit dem wirkstoff tulobuterol |
EP0523150A4 (en) * | 1990-04-06 | 1993-09-29 | Pharmetrix Corporation | Device and method for enhanced administration of physostigmine |
ATE167800T1 (de) * | 1990-04-27 | 1998-07-15 | Allergan Inc | Polymeres arzneimittelabgabesystem |
-
1993
- 1993-04-28 DE DE4313928A patent/DE4313928C2/de not_active Expired - Fee Related
-
1994
- 1994-04-18 IL IL10934094A patent/IL109340A/en not_active IP Right Cessation
- 1994-04-25 AU AU66481/94A patent/AU694115B2/en not_active Ceased
- 1994-04-25 SK SK1343-95A patent/SK134395A3/sk unknown
- 1994-04-25 HU HU9503087A patent/HU220045B/hu not_active IP Right Cessation
- 1994-04-25 NZ NZ265950A patent/NZ265950A/xx unknown
- 1994-04-25 CZ CZ952779A patent/CZ277995A3/cs unknown
- 1994-04-25 WO PCT/EP1994/001281 patent/WO1994025025A2/de not_active Application Discontinuation
- 1994-04-25 EP EP94915110A patent/EP0695182A1/de not_active Withdrawn
- 1994-04-25 JP JP6523855A patent/JPH08509716A/ja active Pending
- 1994-04-25 PL PL94311281A patent/PL175077B1/pl unknown
- 1994-04-25 US US08/553,346 patent/US5869086A/en not_active Expired - Fee Related
- 1994-04-25 CA CA002161520A patent/CA2161520A1/en not_active Abandoned
- 1994-04-26 ZA ZA942874A patent/ZA942874B/xx unknown
- 1994-04-27 YU YU22894A patent/YU22894A/sh unknown
- 1994-04-27 HR HRP4313928.0A patent/HRP940270A2/xx not_active Application Discontinuation
-
1995
- 1995-10-27 KR KR1019950704711A patent/KR960702308A/ko not_active Application Discontinuation
- 1995-10-27 FI FI955161A patent/FI955161A/fi unknown
- 1995-10-27 NO NO954325A patent/NO309174B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO954325L (no) | 1995-10-30 |
NO954325D0 (no) | 1995-10-27 |
WO1994025025A3 (de) | 1995-03-02 |
NO309174B1 (no) | 2000-12-27 |
US5869086A (en) | 1999-02-09 |
IL109340A0 (en) | 1994-07-31 |
NZ265950A (en) | 1997-08-22 |
EP0695182A1 (de) | 1996-02-07 |
AU694115B2 (en) | 1998-07-16 |
HU9503087D0 (en) | 1995-12-28 |
ZA942874B (en) | 1995-07-06 |
AU6648194A (en) | 1994-11-21 |
FI955161A (fi) | 1995-11-24 |
PL311281A1 (en) | 1996-02-05 |
JPH08509716A (ja) | 1996-10-15 |
CA2161520A1 (en) | 1994-11-10 |
HU220045B (hu) | 2001-10-28 |
KR960702308A (ko) | 1996-04-27 |
YU22894A (sh) | 1997-08-22 |
CZ277995A3 (en) | 1996-05-15 |
IL109340A (en) | 1998-10-30 |
HRP940270A2 (en) | 1996-08-31 |
PL175077B1 (pl) | 1998-10-30 |
WO1994025025A2 (de) | 1994-11-10 |
DE4313928C2 (de) | 1996-09-19 |
FI955161A0 (fi) | 1995-10-27 |
DE4313928A1 (de) | 1994-11-03 |
HUT75029A (en) | 1997-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4629578B2 (ja) | 眼疾患治療用経皮吸収型製剤 | |
JP5020061B2 (ja) | 経皮吸収型製剤 | |
US4910205A (en) | Transdermal delivery of loratadine | |
PL175083B1 (pl) | Przezskórny układ terapeutyczny do podawania galantaminy na skórę | |
DE10333393A1 (de) | Transdermales Therapeutisches System mit dem Wirkstoff Pramipexol | |
JPWO2006090782A1 (ja) | 含水系外用貼付剤用組成物及びこの組成物を用いた貼付剤 | |
KR20100126830A (ko) | 경피 흡수 제제 | |
SK134395A3 (en) | Transdermal therapeutical agent and preparation method thereof | |
DE4342174C1 (de) | Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung | |
EP1064939A2 (de) | Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemetischen Behandlung | |
CA1309661C (en) | Transdermal delivery system | |
EP1959938B1 (de) | Matrixkontrolliertes transdermales system mit salzen der ace-hemmer-dicarbonsäuren | |
EP0306926A2 (de) | Salbutamol enthaltendes Pflaster und Verfahren zu dessen Herstellung | |
EP1085858B1 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
EP1368008B1 (de) | Transdermales therapeutisches system zur verabreichung des partiellen dopamin-d2-agonisten aripiprazol | |
JPWO2017006974A1 (ja) | 経皮吸収型貼付剤 | |
DE60108870T2 (de) | Transdermales Verabreichungssystem für die Behandlung von Harnwegserkrankungen | |
DE4229230C2 (de) | Transdermales therapeutisches System mit Pentetrazol als Wirkstoff | |
KR100390870B1 (ko) | 경피투여용 항구토제 조성물 및 이를 포함하는 제제 | |
KR20040084783A (ko) | 국소마취제를 함유하는 패취 제형 | |
JPS63238017A (ja) | 塩酸カルテオロ−ルを含有する水性外用貼付剤 | |
DE10301930A1 (de) | Verfahren zur medikamentösen therapeutischen oder prophylaktischen Behandlung | |
JP2016216384A (ja) | 経皮吸収型製剤 | |
KR20010005871A (ko) | 경피흡수용 기제조성물 및 이 기제조성물을 함유하는 경피흡수제제 |